Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

July 15, 2024 7:00 AM

ORLANDO, FL / ACCESSWIRE / July 15, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) on July 9, 2024, for trademark application Serial Number 98117984, covering the mark "AVERSA™." The Notice of Allowance signifies that the USPTO is expected to grant a trademark registration for...

Read more

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC

July 15, 2024 7:00 AM

MIAMI, FL / ACCESSWIRE / July 15, 2024 / MIRA Pharmaceuticals, Inc. (Nasdaq:MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical development company, today announced promising new findings from recent preclinical studies of its novel oral pharmaceutical marijuana analog, MIRA-55, which is being studied as a potential treatment for anxiety and cognitive decline.The new data confirms MIRA's earlier beliefs regarding MIRA-55's...

Read more

Encision Reports Fourth Quarter Fiscal Year 2024 Results

July 15, 2024 5:00 AM

Encision Inc. (OTCPK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2024 fourth quarter that ended March 31, 2024.The Company posted quarterly net revenue of $1.53 million for a quarterly net loss of $409 thousand, or $(0.03) per diluted share. These results compare to net...

Read more

Hospital Español Auxilio Mutuo De Puerto Rico, Inc. Reports Network Breach

July 12, 2024 9:00 PM

Important Notice About a Privacy MatterSAN JUAN, PUERTO RICO / ACCESSWIRE / July 12, 2024 / On or around September 24, 2023, Hospital Español Auxilio Mutuo de Puerto Rico, Inc. ("Hospital Auxilio Mutuo") discovered an unauthorized access on its network. Upon discovery, Hospital Auxilio Mutuo took immediate action and enlisted the help of experts, retaining outside counsel and IT forensic specialists to determine the cause and extent of the...

Read more

Angle PLC Announces Standard Form for Notification of Major Holdings

July 12, 2024 11:35 AM

TR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:ANGLE plc1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)Non-UK issuer 2. Reason for the notification (please mark the...

Read more

Allure Esthetic Resolves Lawsuit With Washington Attorney General's Office

July 12, 2024 11:00 AM

Allure Esthetic settled claims with Washington's Attorney General's Office, in order to focus on their core mission of providing care to patients and serving their community.SEATTLE, WA / ACCESSWIRE / July 12, 2024 / Allure Esthetic et al., a small family-run medical practice, is pleased to have resolved its case with the Washington's Attorney General's Office. The cooperative settlement, while not admitting fault and resolving claims asserted...

Read more

EIR Supplements Introduces Longevity Formula for Cellular Health and Wellness

July 12, 2024 9:00 AM

MIAMI, FL / ACCESSWIRE / July 12, 2024 / EIR Supplements, a leading innovator in health and wellness, is proud to announce the launch of its flagship product, Longevity Formula. This groundbreaking supplement is designed to support cellular health and overall vitality through advanced genetic research and premium natural ingredients. Longevity Formula is the result of extensive scientific research and development by a team of leading scientists...

Read more

Interim Report January - June 2024

July 12, 2024 1:50 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / July 12, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Second quarter 2024 (Apr 1 - Jun 30) • Net sales amounted to SEK 210.3 million (154.6), corresponding to growth of 36 percent in SEK and 35 percent in local currencies. Organic growth accounted for 35 percent, currency effect 1 percent.• All business areas delivered underlying organic growth adjusted for currency effects: Thoracic disposables 40...

Read more

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

July 11, 2024 4:05 PM

Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the fourth quarter and year-ended April 30, 2024, on Thursday, July 18, 2024, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic)...

Read more

ANY LAB TEST NOW Owner Crowned a Rock Star by Franchise Business Review

July 11, 2024 3:05 PM

ANY LAB TEST NOW®, the nation's leading provider of direct access lab testing, is celebrating a tremendous honor for its El Paso, Texas franchise location. Franchise Business Review (FBR) has named El Paso franchise owner Royal Banks as one of the research firm's 2024 Franchise Rock Stars in the Veterans category.Banks, a U.S. Army veteran, was among hundreds of nominations submitted by franchisors across the nation. At the core of Banks'...

Read more

Promising Data on Transdermal Obesity Formulations Announced by Skinvisible

July 11, 2024 12:15 PM

Results Demonstrate Significant Transdermal Performance of GLP-1 Receptor Agonists and CB-1 Receptor Antagonists Using Invisicare TechnologyLAS VEGAS, NV / ACCESSWIRE / July 11, 2024 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical pharmaceutical research and development company, today announced exciting data demonstrating its transdermal delivery of obesity drugs (and other glucose-...

Read more

AGFA HealthCare and Corista Announce North America Launch of its Integrated Solution for Digital Transformation in Pathology

July 11, 2024 11:45 AM

MORTSEL, BELGIUM / ACCESSWIRE / July 11, 2024 / AGFA HealthCare, a global leader in healthcare imaging management solutions, is pleased to announce that Enterprise Imaging for Pathology, powered by Corista DP3®, is now available in North America*. This specialty solution is built for Pathologists by Pathologists and healthcare software experts; enabling Pathologists to work comfortably in their familiar flow. This sophisticated solution...

Read more

Small Business, Big Impact

July 11, 2024 11:15 AM

NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / CAREThe transformative power of women entrepreneursBy Sarah Hewitt, Director Strive Women, Women's Entrepreneurship at CAREIn the corner of a vegetarian restaurant in Hanoi's Old Quarter, three Vietnamese women sit around bowls of steaming noodles and dumplings, engrossed in discussion.Despite the noise and chaos of the traffic outside, it's peaceful in this small and cozy restaurant filled with...

Read more

Angle PLC Announces Result of 2024 Annual General Meeting

July 11, 2024 10:30 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.For further information:ANGLE plc+44 (0) 1483 343434Andrew Newland, Chief ExecutiveIan Griffiths, Finance Director Berenberg (NOMAD and Broker)Toby Flaux, Ciaran Walsh, Milo Bonser+44 (0) 20 3207 7800FTI ConsultingSimon Conway, Ciara MartinMatthew Ventimiglia...

Read more

Pasadena Villa Outpatient Expands Mental Health Treatment Services Into Michigan With New Troy Clinic

July 11, 2024 9:30 AM

BRENTWOOD, TN / ACCESSWIRE / July 11, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health treatment services, is proud to announce the opening of their new Pasadena Villa Outpatient location in Troy, Michigan. Developed in response to unmet demand for superior mental health treatment services, the facility joins Odyssey's growing network of Pasadena Villa Outpatient locations in Florida, North Carolina, Tennessee, and...

Read more

AcceleDev Chemical LLC Unveils New 5,000-Sq.-Ft. R&D/GMP Production Site in Cranbury, New Jersey, USA

July 11, 2024 9:00 AM

CRANBURY, NJ / ACCESSWIRE / July 11, 2024 / AcceleDev Chemical LLC, a global leader in custom synthesis services, proudly announces the opening of its state-of-the-art 5,000-square-foot R&D and GMP production facility located at 1 Duncan Drive, Cranbury, New Jersey. This significant expansion marks a new chapter in AcceleDev's mission to provide cutting-edge chemistry solutions and support the development of new medicines.AcceleDev's New R&D/GMP...

Read more

Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract - Now 12-Month Data

July 11, 2024 8:30 AM

CARDIFF, UK / ACCESSWIRE / July 11, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is making good progress with eRapa™, its drug to treat Familial Adenomatous Polyposis (FAP).FAP is a mostly inherited condition that puts people at a much greater risk of developing colorectal...

Read more

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech

July 11, 2024 7:15 AM

New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas TherapeuticsFirst instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent litigationUK trial on validity of intellectual property rights EP 3 708 668 B1 and EP 4 023 755 B1 (split poly-A tail technology) began July 10; judgement...

Read more

Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024

July 11, 2024 7:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.Conference Call DetailsDate:Thursday, August 1,...

Read more

Biotricity Announces Accelerated Path to EBITDA Positive

July 11, 2024 7:00 AM

REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its accelerated timeline to achieving EBITDA positive. The company now expects to reach this significant milestone before the end of calendar 2024, earlier than previously anticipated."Our strategic initiatives and technological advancements...

Read more